In this issue:
Partial biopsy accuracy in cutaneous melanoma management
Pre-SLNB wide local excision for primary head/neck melanoma
Face-to-face vs. teledermatology for diagnosing skin cancer
NNBs for diagnosing cutaneous melanoma
Keratinocyte carcinoma incidence/risk after first solid organ transplant
5-year survival with nivolumab + ipilimumab in advanced melanoma
Targeted and immunotherapies in melanoma brain metastases
Nivolumab in advanced melanoma subgroups who progressed on/after ipilimumab
Prolonged OS following metastasectomy in stage IV melanoma
Pembrolizumab vs. ipilimumab in advanced melanoma
Please login below to download this issue (PDF)